English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Objectives : ‘Reconsideration about Nomenclature of Herbs Listed in the Kor ean Pharmacopoeia’ was published by Doh and Lee with absolute misconception of nomenclature. A critical review of Doh and Lee's paper is given, to correct the confused the concept of nomenclature and to provide proper scientific name for taxa which are discussed.Methods : This paper discusses the proper usage, as mandated by the Inter national Code of Nomenclature. Adherence to the rules described in this paper should reduce th e present confusion in the nomenclature of scientific names listed in the Korean Pharmacopoeia.Results : Although Doh and Lee proposed four categories to correct the scientific names of the Korean Pharmacopoeia using available botanical databases, they failed to show how nomenclatural concepts are applicable due to misconception of legitimacy and the confusion about synonym. From a nomenclatural perspective, 'accepted name' or 'recommended name' is a subject ive term which used to be employed for convenience in a certain databases or working group without nom enclatural meaning. Doh and Lee also pointed out the standardization of author citation. However, they misse d the importance of author citation error such as basionym or validating authors.Conclusions : Doh and Lee were not able to solve nomenclatural problems of t he Korea Pharmacopoeia due to lack of clarity on the nomenclature code. We strongly recommend that KFDA has to commence extensive nomenclatural review for the next revision of Korea Pharmacopoeia.Key words : Critical Review; ICN; Korean Pharmacopoeia; Legitimacy; Nomencl ature; Synonym

A Critical Review of 'Reconsideration about Nomenclature of Herbs Listed in the Korean Pharmacopoeia'